Ron Squarer

Array BioPharma

Chief Executive Officer

Overview

Ron Squarer made an average of $3.5M in compensation at Array BioPharma from 2013 to 2018.

Annual data

2018

In 2018, Ron Squarer earned a total compensation of $5.6M as Chief Executive Officer at Array BioPharma.

Ranking1,453 out of 10,945
Percentile86.7%

Ron Squarer's 2018 compensation ranked 1,453rd out of 10,945 executive pay records tracked by us this year.

Squarer earned more than 86.7% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking130 out of 1,249
Percentile89.6%

In the industry group of Drugs, Squarer's pay ranked 130th out of 1,249 executive pay records tracked by us in 2018.

Squarer earned more than 89.6% of executives in this group.

Non-Equity Incentive Plan$473,582
Option Awards$3,331,808
Salary$615,760
Stock Awards$1,092,000
Other$51,716
Total$5,564,866

Squarer received $3.3M in option awards, which accounts for 59.87% of total compensation.

Squarer also received $473.6K in non-equity incentive plan, $615.8K in salary, $1.1M in stock awards and $51.7K in other compensation.

2017

In 2017, Ron Squarer earned a total compensation of $4.7M as Chief Executive Officer at Array BioPharma.

Ranking1,929 out of 13,783
Percentile86.0%

Ron Squarer's 2017 compensation ranked 1,929th out of 13,783 executive pay records tracked by us this year.

Squarer earned more than 86.0% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking132 out of 1,567
Percentile91.6%

In the industry group of Drugs, Squarer's pay ranked 132nd out of 1,567 executive pay records tracked by us in 2017.

Squarer earned more than 91.6% of executives in this group.

Non-Equity Incentive Plan$402,127
Option Awards$2,845,285
Salary$600,010
Stock Awards$824,063
Other$52,000
Total$4,723,485

Squarer received $2.8M in option awards, which accounts for 60.24% of total compensation.

Squarer also received $402.1K in non-equity incentive plan, $600K in salary, $824.1K in stock awards and $52K in other compensation.

2016

In 2016, Ron Squarer earned a total compensation of $2M as Chief Executive Officer at Array BioPharma.

Ranking4,929 out of 14,038
Percentile64.9%

Ron Squarer's 2016 compensation ranked 4,929th out of 14,038 executive pay records tracked by us this year.

Squarer earned more than 64.9% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking403 out of 1,500
Percentile73.1%

In the industry group of Drugs, Squarer's pay ranked 403rd out of 1,500 executive pay records tracked by us in 2016.

Squarer earned more than 73.1% of executives in this group.

Non-Equity Incentive Plan$435,000
Option Awards$695,592
Salary$575,260
Stock Awards$226,875
Other$47,341
Total$1,980,068

Squarer received $695.6K in option awards, which accounts for 35.13% of total compensation.

Squarer also received $435K in non-equity incentive plan, $575.3K in salary, $226.9K in stock awards and $47.3K in other compensation.

2015

In 2015, Ron Squarer earned a total compensation of $4.1M as Chief Executive Officer at Array BioPharma.

Ranking2,124 out of 13,589
Percentile84.4%

Ron Squarer's 2015 compensation ranked 2,124th out of 13,589 executive pay records tracked by us this year.

Squarer earned more than 84.4% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking213 out of 1,485
Percentile85.7%

In the industry group of Drugs, Squarer's pay ranked 213th out of 1,485 executive pay records tracked by us in 2015.

Squarer earned more than 85.7% of executives in this group.

Non-Equity Incentive Plan$343,262
Option Awards$1,954,337
Salary$558,250
Stock Awards$1,170,438
Other$46,661
Total$4,072,948

Squarer received $2M in option awards, which accounts for 47.98% of total compensation.

Squarer also received $343.3K in non-equity incentive plan, $558.3K in salary, $1.2M in stock awards and $46.7K in other compensation.

2014

In 2014, Ron Squarer earned a total compensation of $2.2M as Chief Executive Officer at Array BioPharma.

Ranking4,149 out of 12,932
Percentile67.9%

Ron Squarer's 2014 compensation ranked 4,149th out of 12,932 executive pay records tracked by us this year.

Squarer earned more than 67.9% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking356 out of 1,316
Percentile72.9%

In the industry group of Drugs, Squarer's pay ranked 356th out of 1,316 executive pay records tracked by us in 2014.

Squarer earned more than 72.9% of executives in this group.

Non-Equity Incentive Plan$341,825
Option Awards$1,237,019
Salary$548,750
Other$62,675
Total$2,190,269

Squarer received $1.2M in option awards, which accounts for 56.48% of total compensation.

Squarer also received $341.8K in non-equity incentive plan, $548.8K in salary and $62.7K in other compensation.

2013

In 2013, Ron Squarer earned a total compensation of $2.4M as Chief Executive Officer at Array BioPharma.

Ranking3,256 out of 12,074
Percentile73.0%

Ron Squarer's 2013 compensation ranked 3,256th out of 12,074 executive pay records tracked by us this year.

Squarer earned more than 73.0% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking194 out of 1,102
Percentile82.4%

In the industry group of Drugs, Squarer's pay ranked 194th out of 1,102 executive pay records tracked by us in 2013.

Squarer earned more than 82.4% of executives in this group.

Non-Equity Incentive Plan$329,725
Option Awards$1,275,853
Salary$528,192
Other$246,976
Total$2,380,746

Squarer received $1.3M in option awards, which accounts for 53.59% of total compensation.

Squarer also received $329.7K in non-equity incentive plan, $528.2K in salary and $247K in other compensation.